COVID-19/SARS-CoV-2: Infection, Vaccination and Immune Response

Dear Colleagues,

It has been almost three years combating COVID-19, and still, major aspects of the immune response following vaccination and/or infection remain to be fully understood. Multiple vaccines have been developed which effectively slowed the pandemic, which is encouraging; however, emerging variants have compromised the efficacy of available vaccines and made it necessary to develop new vaccines. Current research has, therefore, focused on the development of both new variant-specific and pan-coronaviral vaccines. Apart from vaccines, the efficacy of therapeutic antibodies has also been influenced in the face of evolving variants, which requires the development of variant-resistant broadly neutralizing antibodies and other therapeutic agents.

Immunity acquired through vaccination or infection naturally weakens with time, which further increases the risk of infections or re-infections. Although much research has been conducted in a relatively short span of time, a clear understanding of the detailed immune response is still needed.

For this Special Issue, we invite contributions that focus on the advancement of our understanding of SARS-CoV-2 infections, the immunological responses, and new vaccine strategies. Original research articles and reviews are welcome.

Dr. Athanasios G Michos
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.